Skip to content
10-Q

Quarterly Report

FIRST CHINA PHARMACEUTICAL GROUP, INC.

0001062993-12-001868

← back to feed
Filed
May 18, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 15, 2012 59.66M sh
Shares Diluted Q1 2012 · Mar 31, 2012 59.66M sh
Shares Diluted Q1 2012 · Mar 31, 2011 55.47M sh
Capex Q1 2012 · Mar 31, 2012 $16.22K
Capex Q1 2012 · Mar 31, 2011 $2.89K
Operating Cash Flow Q1 2012 · Mar 31, 2012 $1.78M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $3.27M
Short Term Debt Q1 2012 · Mar 31, 2012 $1.35M
Short Term Debt Q1 2012 · Dec 31, 2011 $0
Cash And Equivalents Q1 2012 · Mar 31, 2012 $3.97M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $3.64M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $2.74M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $1.13M
Stockholders Equity Q1 2012 · Mar 31, 2012 −$5.25M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$4.09M
Current Liabilities Q1 2012 · Mar 31, 2012 $31.25M
Current Liabilities Q1 2012 · Dec 31, 2011 $22.43M
Total Liabilities Q1 2012 · Mar 31, 2012 $34.19M
Total Liabilities Q1 2012 · Dec 31, 2011 $24.11M
Current Assets Q1 2012 · Mar 31, 2012 $28.04M
Current Assets Q1 2012 · Dec 31, 2011 $19.84M
Total Assets Q1 2012 · Mar 31, 2012 $28.94M
Total Assets Q1 2012 · Dec 31, 2011 $20.02M
Eps Diluted Q1 2012 · Mar 31, 2012 −$0.02
Eps Diluted Q1 2012 · Mar 31, 2011 −$0.01
Eps Basic Q1 2012 · Mar 31, 2012 −$0.02
Eps Basic Q1 2012 · Mar 31, 2011 −$0.01
Sga Expense Q1 2012 · Mar 31, 2012 $686.64K
Sga Expense Q1 2012 · Mar 31, 2011 $549.67K
Net Income Q1 2012 · Mar 31, 2012 −$1.17M
Net Income Q1 2012 · Mar 31, 2011 −$314.54K
Operating Income Q1 2012 · Mar 31, 2012 $274.17K
Operating Income Q1 2012 · Mar 31, 2011 $160.45K
Gross Profit Q1 2012 · Mar 31, 2012 $1.06M
Gross Profit Q1 2012 · Mar 31, 2011 $1.3M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $11.13M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $6.08M
Revenue Q1 2012 · Mar 31, 2012 $12.19M
Revenue Q1 2012 · Mar 31, 2011 $7.38M